Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,562

Popular energy drinks may give you a boost, but they may also contribute to possible serious heart conditions, findings show.

A team of researchers, led by a Texas A&M University professor, has found that some energy drinks have adverse effects on the muscle cells of the heart.

The study, led by Dr. Ivan Rusyn, a professor in the Veterinary Integrative Biosciences (VIBS) Department at the Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVMBS), was published in Food and Chemical Toxicology. In it, researchers observed cardiomyocytes – human heart cells grown in a laboratory – exposed to some energy drinks showed an increased beat rate and other factors affecting cardiac function.

Read more | >

57:03 “A tool that would be used for millenia.”

Foresight biotech & health extension group sponsored by 100 plus capital.

Accelerator applications are open now: https://foresight.org/biotech-health-extension-program.

Industry blindspots: Unincentivized work that could dramatically advance progress on aging.

SONIA ARRISON, 100 Plus Capital.

Continue reading “Aging industry blindspots | S Arrison, 100 Plus Capital, K Pfleger, AgingBiotech.info, M West, AgeX” | >

The adeno-associated viruses often used as vectors to deliver gene therapy can trigger unwanted and sometimes dangerous immune responses. Now, a Harvard University team led by renowned geneticist George Church, Ph.D., has developed a way to “cloak” AAVs from immune surveillance. They’ve spun off Ally Therapeutics to develop it.

Read more | >

Stimuli-responsive control of drug activation can mitigate issues caused by poor drug selectivity. Now, it has been shown that mechanical force—induced by ultrasound—can be used to activate drugs in three different systems. This approach has enabled the activation of antibiotics or a cytotoxic anticancer agent from synthetic polymers, polyaptamers and nanoparticle assemblies.

Read more | >

Cell-Intrinsic Learning And Memory Storage Dynamics — Dr. David Glanzman Ph.D., Professor, in the Department Integrative Biology and Physiology, at UCLA College of the Life Sciences.

Dr. David Glanzman is Professor, in the Department Integrative Biology and Physiology, at UCLA College of the Life Sciences, Professor in the Department of Neurobiology in the David Geffen School of Medicine, and Member, Brain Research Institute.

Dr. Glanzman has a B.A. in Psychology from Indiana University Bloomington and a Ph.D. in Psychology from Stanford University.

Dr. Glanzman is interested in the cell biology of learning and memory in simple organisms.

In Dr. Glanzman’s lab research they use two animals, the marine snail Aplysia californica, and the zebrafish (Danio rerio).

Continue reading “Dr. David Glanzman Ph.D. — UCLA — Studying Cell-Intrinsic Learning And Memory Storage Dynamics” | >